{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:51:10Z","timestamp":1791319870936,"version":"4.3.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":96,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06162-4","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:45:38Z","timestamp":1782899138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factor target achievement in relation to incident cardiovascular disease among individuals with cardiovascular-kidney-metabolic syndrome stage 1\u20133: results from a nationwide cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Bin-Bin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6263-7228","authenticated-orcid":false,"given":"Guo-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"20","key":"6162_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"21","key":"6162_CR2","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"18","key":"6162_CR3","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jacc.2024.03.368","volume":"83","author":"AMK Minhas","year":"2024","unstructured":"Minhas AMK, Mathew RO, Sperling LS, Nambi V, Virani SS, Navaneethan SD, Shapiro MD, Abramov D. Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States. J Am Coll Cardiol. 2024;83(18):1824\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"6162_CR4","first-page":"949","volume":"37","author":"H Cardiovascular","year":"2024","unstructured":"Center For Cardiovascular Diseases The Writing Committee Of The Report On, Cardiovascular H. Diseases In China N: Report on Cardiovascular Health and Diseases in China 2023: An Updated Summary. Biomed Environ Sci. 2024;37(9):949\u201392.","journal-title":"Biomed Environ Sci"},{"issue":"10","key":"6162_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","volume":"110","author":"S Malik","year":"2004","unstructured":"Malik S, Wong ND, Franklin SS, Kamath TV, L\u2019Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245\u201350.","journal-title":"Circulation"},{"issue":"20","key":"6162_CR6","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despr\u00e9s JP, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"20","key":"6162_CR7","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","volume":"384","author":"CE Lewis","year":"2021","unstructured":"Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, et al. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2021;384(20):1921\u201330.","journal-title":"N Engl J Med"},{"issue":"17","key":"6162_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jacc.2025.07.057","volume":"86","author":"Y Yin","year":"2025","unstructured":"Yin Y, Wang X, Zheng K, Sun T, Zhang B, Si R, Xiao J, Jiao Y, Wang S, Wang Y, et al. Safety and Efficacy of Intensive BP Control in Cardiovascular-Kidney-Metabolic Syndrome: A Post Hoc Analysis of the SPRINT Trial. J Am Coll Cardiol. 2025;86(17):1452\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6162_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2023.04.052","volume":"82","author":"J Morales","year":"2023","unstructured":"Morales J, Handelsman Y. Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;82(2):161\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"6162_CR10","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.2337\/dc23-S009","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S140\u201357.","journal-title":"Diabetes Care"},{"issue":"9784","key":"6162_CR11","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181\u201392.","journal-title":"Lancet"},{"issue":"15","key":"6162_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","volume":"137","author":"RP Giugliano","year":"2018","unstructured":"Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbal\u00e1n R, \u0160pinar J, Park JG, White JA, Bohula EA, Braunwald E. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation. 2018;137(15):1571\u201382.","journal-title":"Circulation"},{"issue":"1","key":"6162_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1186\/s12872-025-05216-3","volume":"25","author":"W Zhao","year":"2025","unstructured":"Zhao W, Yan Q, Mou C. Physical activity and cardiovascular-metabolic disease risk across cardiovascular-kidney-metabolic syndrome stages: a population-based cohort study. BMC Cardiovasc Disord. 2025;25(1):748.","journal-title":"BMC Cardiovasc Disord"},{"issue":"16","key":"6162_CR14","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.116.025961","volume":"135","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbj\u00f6rnsdottir S. Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus. Circulation. 2017;135(16):1522\u201331.","journal-title":"Circulation"},{"issue":"6","key":"6162_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jchf.2023.01.006","volume":"11","author":"M Kou","year":"2023","unstructured":"Kou M, Wang X, Ma H, Li X, Heianza Y, Qi L. Degree of Joint Risk Factor Control and Incident Heart Failure in Hypertensive Patients. JACC Heart Fail. 2023;11(6):678\u201388.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"6162_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"6162_CR17","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/aje\/kwz170","volume":"188","author":"X Chen","year":"2019","unstructured":"Chen X, Crimmins E, Hu PP, Kim JK, Meng Q, Strauss J, Wang Y, Zeng J, Zhang Y, Zhao Y. Venous Blood-Based Biomarkers in the China Health and Retirement Longitudinal Study: Rationale, Design, and Results From the 2015 Wave. Am J Epidemiol. 2019;188(11):1871\u20137.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"6162_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"42","key":"6162_CR19","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","volume":"46","author":"F Mach","year":"2025","unstructured":"Mach F, Koskinas KC, van Roeters JE, Tokg\u00f6zo\u011flu L, Badimon L, Baigent C, Benn M, Binder CJ, Catapano AL, De Backer GG, et al. 2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46(42):4359\u201378.","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"6162_CR20","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S19\u201340.","journal-title":"Diabetes Care"},{"issue":"12","key":"6162_CR21","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.2337\/dc22-0886","volume":"45","author":"M Rietz","year":"2022","unstructured":"Rietz M, Lehr A, Mino E, Lang A, Szczerba E, Schiemann T, Herder C, Saatmann N, Geidl W, Barbaresko J, et al. Physical Activity and Risk of Major Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review and Meta-Analysis of Observational Studies. Diabetes Care. 2022;45(12):3101\u201311.","journal-title":"Diabetes Care"},{"issue":"9","key":"6162_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"6","key":"6162_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","volume":"149","author":"SS Khan","year":"2024","unstructured":"Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E, et al. Development and Validation of the American Heart Association\u2019s PREVENT Equations. Circulation. 2024;149(6):430\u201349.","journal-title":"Circulation"},{"key":"6162_CR24","doi-asserted-by":"crossref","unstructured":"KDIGO. 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024, 105(4s):S117\u2013s314.","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"10","key":"6162_CR25","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.2337\/dc24-0864","volume":"47","author":"ZG Huang","year":"2024","unstructured":"Huang ZG, Gao JW, Chen ZT, Zhang HF, You S, Xiong ZC, Wu YB, Gao QY, Wang JF, Chen YX, et al. Comprehensive Multiple Risk Factor Control in Type 2 Diabetes to Mitigate Heart Failure Risk: Insights From a Prospective Cohort Study. Diabetes Care. 2024;47(10):1818\u201325.","journal-title":"Diabetes Care"},{"issue":"3","key":"6162_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.mayocp.2023.05.008","volume":"99","author":"M Kou","year":"2024","unstructured":"Kou M, Wang X, Ma H, Li X, Heianza Y, Qi L. Degree of Risk Factor Control and Incident Cardiovascular Diseases in Patients With Hypertension. Mayo Clin Proc. 2024;99(3):387\u201399.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"6162_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/dom.15443","volume":"26","author":"X Wang","year":"2024","unstructured":"Wang X, Ma H, Li X, Liang Z, Fonseca V, Qi L. Risk factor control and incident cardiovascular disease in patients with diabetes: Sex-specific relations. Diabetes Obes Metab. 2024;26(4):1421\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"6162_CR28","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1111\/dom.16293","volume":"27","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang C, Zhao L, Wang Z, Zhou X, Yang W, Meng X. Association of depression, traditional risk factor control and genetic risk with incident cardiovascular disease among individuals with prediabetes: A population-based prospective study from UK biobank. Diabetes Obes Metab. 2025;27(5):2833\u201343.","journal-title":"Diabetes Obes Metab"},{"issue":"14","key":"6162_CR29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jacc.2024.06.041","volume":"84","author":"T Geng","year":"2024","unstructured":"Geng T, Xu W, Gao H, Zhang J, Zou J, Wang K, Li J, Guo L, Wang G, Chen S, et al. Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults. J Am Coll Cardiol. 2024;84(14):1313\u201324.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"6162_CR30","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","volume":"76","author":"MJ Domanski","year":"2020","unstructured":"Domanski MJ, Tian X, Wu CO, Reis JP, Dey AK, Gu Y, Zhao L, Bae S, Liu K, Hasan AA, et al. Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. J Am Coll Cardiol. 2020;76(13):1507\u201316.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6162_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.110.002774","volume":"125","author":"N Allen","year":"2012","unstructured":"Allen N, Berry JD, Ning H, Van Horn L, Dyer A, Lloyd-Jones DM. Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project. Circulation. 2012;125(1):37\u201344.","journal-title":"Circulation"},{"issue":"15","key":"6162_CR32","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577\u201389.","journal-title":"N Engl J Med"},{"issue":"1","key":"6162_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/01.CIR.0000048892.83521.58","volume":"107","author":"EG Lakatta","year":"2003","unstructured":"Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a set up for vascular disease. Circulation. 2003;107(1):139\u201346.","journal-title":"Circulation"},{"issue":"1","key":"6162_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12933-024-02371-3","volume":"23","author":"R Minutolo","year":"2024","unstructured":"Minutolo R, Simeon V, De Nicola L, Chiodini P, Galiero R, Rinaldi L, Caturano A, Vetrano E, Sardu C, Marfella R, et al. Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial. Cardiovasc Diabetol. 2024;23(1):285.","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06162-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06162-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06162-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:02:52Z","timestamp":1791316972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06162-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6162"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06162-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for this project was granted by the Biomedical Ethics Committee of Peking University (Beijing, China) (IRB00001052-11015), with our study adhering strictly to the principles outlined in the Declaration of Helsinki, and obtaining informed consent from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"870"}}